Small Product, Big Innovation

April 14, 2022

Congratulations to iMFLUX and Procter & Gamble on developing a nasal swab so innovative that it was recently awarded US Design Patent D942,000. The nasal swab will improve the speed of COVID-19 testing and help ease testing supply issues.

P&G’s Personal Health care team collaborated with iMFLUX to develop a novel fully injection-molded polypropylene nasal swab — so healthcare workers can collect samples from the front of the nose rather than through the long cavity between the nose and the mouth. Rhinostics, a Harvard University spin-off company, has licensed the swab and is pursuing Emergency Use Authorization for home collection testing for COVID-19. To read the full P&G press release, click here.

Marshall Gerstein is proud to have worked on the US Design Patent for the new nasal swab. To see the full issued patent, click here.

the US Design Patent for the new nasal swab

Offsite Notice

By clicking “Proceed” below, you will be opening a new browser window and leaving our website.